Identifying the Patient at Risk of Foot Ulceration

Wounds

Volumn 12, Issue 6 SUPPL. B, 2000, Pages

  Rosenblum, Barry I ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034556895     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gibbons GW, Marcaccio EJ, Burgess AM, et al. Improved quality of diabetic foot care, 1984 vs. 1990. Arch Surg 1993;128:576-81.
2. Steed DL, the Diabetic Ulcer Study Group. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg 1995;21:71-81.
3. Grayson ML, Gibbons GW, Habershaw GM, et al. Ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limbthreatening foot infections in diabetic patients. Clin Inf Dis 1994;18:683-93.
4. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In: Harris MI, Cowie CC, Stem MP, et al. (eds). Diabetes in America, Second Edition. Washington, DC: US Govt. Printing Office, 1995 (NIH publ. No. 95-1468).
5. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: Basis for prevention. Diabetes Care 1990;13:513-21.
6. Armstrong DG, Lavery LA, Harkless LB. Treatment-based classification system for assessment and care of diabetic feet. J Amer Podiatr Med Assoc 1996;86:311-6.
7. Mayfield JA, Reiber GE, Sanders LJ, et al. Preventive foot care in people with diabetes. Diabetes Care 1998;21:2161-77.
8. Moss SE, Klein R, Klein BEK. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 1992;152:610-6.
9. Kumar S, Ashe HA, Fernando DJS, et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: A population-based study. Diabetic Med 1994;11:480-4.
10. Litzelman DK, Marriott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NTDDM. Diabetes Care 1997;20:1273-5.
11. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort The Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-24.
12. Veves A, Sarnow MR. Diagnosis, classification, and treatment of diabetic peripheral neuropathy. Clin Podiatr Med Surg 1995;12:19-30.
13. American Diabetes Association, American Academy of Neurology. Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes Care 1988;11:592-7.
14. Maser RE, Nielsen VK, Bass EB, et al. Measuring diabetic neuropathy, assessment and comparison of clinical examination and quantitative sensory testing. Diabetes Care 1989;12:270-5.
15. Simeone LR, Veves A. Screening techniques to identify the diabetic patient at risk of ulceration. J Amer Podiatr Med Assoc 1997;87:313-7.
16. Boulton AJM, Kubrusly DB, Bowker JH, et al. Impaired vibratory perception and diabetic foot ulceration. Diabetic Med 1986;3:335-7.
17. Young MJ, Breddy JL, Veves A, et al. The prediction of diabetic neuropathic foot ulceration using vibratory perception thresholds: A prospective study. Diabetes Care 1994;17:557-60.
18. Olmos PR, Cataland S, O'Dorisio TM, et al. The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with non-insulin-dependent diabetes. Am J Med Sci 1995;309:76-82.
19. Bell-Krotoski J, Tomancik E. The repeatability of testing with Semmes-Weinstein monofilaments. J Hand Surg 1987;12A:155-61.
20. Valk GD, deSonnaville JJJ, van Houtum WH, et al. The assessment of diabetic polyneuropathy in daily clinical practice: Reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination. Muscle Nerve 1997;20:116-8.
21. Dyck PJ. Detection, characterization, and staging of polyneuropathy: Assessed in diabetics. Muscle Nerve 1988;11:21-32.
22. Veves A, Murray HJ, Young MJ, et al. The risk of foot ulceration in diabetic patients with high foot pressure: A prospective study. Diabetologia 1992;35:660-3.
23. Frykberg RG, Lavery LA, Pham H. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 1998;21:1714-9.
24. Mueller MJ, Diamond JE, Delitto A, et al. Insensitivity, limited joint mobility, and plantar ulcers in patients with diabetes mellitus. Phys Ther 1989;69:453-62.
25. Howleski JJ, Moss KM, Stess RM, et al. Prevalence of foot pathology and lower extremity complications in a diabetic outpatient clinic. J Rehab Res 1989;26:35-44.
26. Fernando DJS, Masson EA, Veves A. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 1991;14:8-11.
27. Lavery LA, Lavery DC, Quebedeax-Farnham TL. Increased foot pressures after great toe amputation in diabetes. Diabetes Care 1995;18:1460-2.
28. Kannel WB, McGee DL. Diabetes and cardiovascular disease: The Framingham Study. J Am Med Assoc 1979;241:2035-8.
29. Melton LJ III, Macken KM, Palumbo PJ, et al. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care 1980;3:648-54.
30. Strandness DE Jr, Priest RE, Giggons GE. Combined clinical and pathologic study of diabetic and nondiabetic peripheral arterial disease. Diabetes 1964;13:366-72.
31. Boyko EJ, Ahroni JH, Davignon DSV, et al. Diagnostic utility of the history and physical examination for peripheral vascular disease among patients with diabetes mellitus. J Clin Epidemiol 1997;50:659-68.
32. Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes: Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18-20, 1992 New Orleans. Circulation 1993;88:819-28.